408-940-5056
Signup
Login
Toggle navigation
HOME
Products
TradeVisor™ for US Stocks & ETFs
Pricing
Support
Free Resources
Free Daily Stock Analysis
Events
videos
About
About Us
Contact
In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.
×
TradeVisor™ Product Demo
Follow
CytomX Therapeutics, Inc.. Trade Record
CTMX Daily Analysis
NASDAQ:CTMX CytomX Therapeutics, Inc. stock gains 8.79% Exit Feb 14, 2019 a Trade Record by priceseries
Trade Chart
About CytomX Therapeutics, Inc.
Preclinical biotech developing tumor-activated cancer immunotherapies.
Trade Information
Trade Type
LONG
ReliabilityScore™
95.74
Entry Date
Jan 30, 2019
Entry Price
16.74
Sell Date
Feb 14, 2019
Sell Price
18.21
Net Gain
8.79%
Hold Time
11 Trading Days